TrialAntimicrobial agents and chemotherapy2013

Echocardiogram study to evaluate the effect of the novel hepatitis C virus NS5A inhibitor GSK2336805 on cardiac contractility in healthy subjects.

D A Wilfret et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.